Yasser Rodriguez, MD
Clinical Cardiac Electrophysiology · Lawrenceville, GANPI 1336433143
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Abbott at 43.3% of the total. 2025 is the largest year on record at $9,925, 4.7 times the $2,104 reported in 2019.
Across 409 payments — averaging $89.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$16K
- Medtronic$11K
- Biotronik Inc.$4K
- Biosense Webster, Inc.$1K
- Boston Scientific$1K
- Medical Device Business Services, Inc.$730
- plus $3K from 24 others
What the payments were for
- Consulting fees$7,89621%
- Speaking & faculty fees$280%
- Travel & lodging$11,85932%
- Food & beverage$16,95046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 115 | $15,923 |
| Medtronic(2 entities) | 112 | $10,659 |
| Biotronik Inc. | 26 | $3,703 |
| Biosense Webster, Inc. | 44 | $1,476 |
| Boston Scientific | 37 | $1,474 |
| Medical Device Business Services, Inc. | 3 | $730 |
| Acutus Medical, Inc. | 4 | $474 |
| Elutia, Inc. | 4 | $416 |
| Cardiva Medical, Inc. | 15 | $376 |
| Boehringer Ingelheim | 7 | $273 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $217 |
| Johnson & Johnson | 5 | $189 |
| Philips North America LLC | 2 | $160 |
| Novartis | 2 | $118 |
| E.r. Squibb & Sons, L.L.C. | 5 | $114 |
| Pfizer | 3 | $54 |
| Cvrx, Inc. | 2 | $50 |
| Amgen | 3 | $45 |
| Catheter Precision Inc. | 1 | $32 |
| Edwards Lifesciences | 1 | $29 |
| Convatec Inc. | 1 | $29 |
| BD | 1 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Abiomed | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Bayer | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$6,946
- ENSITE$2,577
- ENSITE PRECISION$2,121
- Micra$1,446
- AVEIR$1,112
- Carto 3$1,096
- Arctic Front$1,067
- BioMonitor$796
- Acticor 7 VR-T DX$524
- GENERAL - THERAPIES$402
- Rivacor 7 DR-T$400
- Edora 8 DR-T$400
- Solia$400
- ECM Patch,Pouch$387
- ARCTIC FRONT ADVANCE$377
- Cobalt$349
- COBALT DR MRI SURESCAN$277
- SelectSecure$255
- Ensite Cardiac Mapping System$252
- CareLink$168
How this compares
$36,733 in reported general payments places this provider in the 65th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 213 | $209,296 |
| XareltoRivaroxaban | 104 | $94,978 |
| JardianceEmpagliflozin | 11 | $13,229 |
| PradaxaDabigatran Etexilate Mesylate | 11 | $2,492 |
| Metoprolol Succinate | 151 | $2,240 |
| Amiodarone Hcl | 26 | $1,244 |
| Dofetilide | 14 | $978 |
| Nadolol | 14 | $413 |
| Atorvastatin Calcium | 30 | $344 |
| Losartan Potassium | 23 | $281 |
| Spironolactone | 18 | $189 |
| Metoprolol Tartrate | 30 | $154 |
| Carvedilol | 17 | $148 |
| Rosuvastatin Calcium | 17 | $134 |
| Atenolol | 16 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $54 | $209,296213 claims |
| Johnson & JohnsonXarelto | $189 | $94,978104 claims |
| Boehringer IngelheimJardiance, Pradaxa | $273 | $15,72122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Lawrenceville
- Niraj SharmaLawrenceville$61K
- Thomas MiddourLawrenceville$25K
- David WilsonLawrenceville$13K
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- David NewtonSavannah$225K
- Michael LloydAtlanta$221K
- Kent NilssonAthens$198K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.